about
Roles of genetic polymorphisms in the folate pathway in childhood acute lymphoblastic leukemia evaluated by Bayesian relevance and effect size analysis.Pharmacogenetic analysis of high-dose methotrexate treatment in children with osteosarcoma.Clinical relations of methotrexate pharmacokinetics in the treatment for pediatric osteosarcoma.HLA-DRB1*07:01-HLA-DQA1*02:01-HLA-DQB1*02:02 haplotype is associated with a high risk of asparaginase hypersensitivity in acute lymphoblastic leukemia.Pharmacogenetics of anthracyclines.[Flow cytometry in the diagnosis of hemophagocytic lymphohistiocytosis in a case with fatal outcome].Some GCR Polymorphisms (N363S, ER22/23EK, and Bcl-1) May Influence Steroid-induced Toxicities and Survival Rates in Children With ALL.Teenagers and young adults with cancer in Europe: from national programmes to a European integrated coordinated project.Associations of novel genetic variations in the folate-related and ARID5B genes with the pharmacokinetics and toxicity of high-dose methotrexate in paediatric acute lymphoblastic leukaemia.The glucocorticoid receptor gene polymorphism N363S predisposes to more severe toxic side effects during pediatric acute lymphoblastic leukemia (ALL) therapy.Absolute Lymphocyte Count (ALC) after Induction Treatment Predicts Survival of Pediatric Patients with Acute Lymphoblastic Leukemia.Urine catecholamines in paediatrics.Impact of single nucleotide polymorphisms of cytarabine metabolic genes on drug toxicity in childhood acute lymphoblastic leukemia.[Extracellular vesicles and their role in hematological malignancies].[New and traditional directions in the biology and management of childhood acute lymphoblastic leukemia].Possible roles of genetic variations in chemotherapy related cardiotoxicity in pediatric acute lymphoblastic leukemia and osteosarcoma.[Epigenetic effects affecting etoposide distribution and metabolism in the human body]ABCC1polymorphisms in anthracycline-induced cardiotoxicity in childhood acute lymphoblastic leukaemiaAssociation of some rare haplotypes and genotype combinations in the MDR1 gene with childhood acute lymphoblastic leukaemiaThe role of ABC-transporter gene polymorphisms in chemotherapy induced immunosuppression, a retrospective study in childhood acute lymphoblastic leukaemiaSubacute cardiotoxicity caused by anthracycline therapy in children: can dexrazoxane prevent this effect?Late immune recovery in children treated for malignant diseases[Subacute cardiotoxicity caused by anthracycline therapy in children: can dexrazoxane prevent this effect?]Comparison of pharmacokinetics and toxicity after high-dose methotrexate treatments in children with acute lymphoblastic leukemia[Examination of late pulmonary toxicity in children treated for malignancies]Circulating microRNAs as minimal residual disease biomarkers in childhood acute lymphoblastic leukemia
P50
Q34934593-5EEEF6FA-1445-41D4-83DE-F5ECB5F77B1CQ37705973-FC80D3B8-E467-446D-85F0-8ABFCA8EEFAFQ38015163-EBD6009B-B892-41CB-9DF5-EAD5151344A6Q38735393-DA02AAD4-097B-481B-A3C9-98CF21A024ACQ38856218-D6D49B8A-4350-4D90-8B55-B1ACEB566032Q40216294-3E8601BE-FB9D-4DDB-B512-12A342A4B652Q40815418-B7E2A6D8-6EA4-4107-9DB9-441912F67F15Q41517323-9FDD4EE8-3113-4CDE-98E1-0C1478105382Q42706096-8EB9C285-7C6E-487D-A77C-FD49EEA5D8DEQ44644877-7BBAF0FD-37A9-4BE9-A1DA-BE6895DAA5CCQ50922836-15826D2A-FB54-431C-9A6F-C38761A4D047Q52845666-BD717294-7BAA-4E90-8DFC-3209BA8E8F37Q53653257-CE178E42-C6B8-415E-BE4A-B5AA435BF64FQ53772153-6E5C150A-FBA0-4DD1-AC80-B0481539966FQ54110216-09C9F38E-9D70-4881-95F3-E35E09A8AA8AQ55518023-B3CD5234-52C5-4C32-B392-9803C6895BB0Q57173357-F370D827-6DDC-4EA9-B929-FB06194A831EQ59662726-78341F9C-21CC-43CC-8FAD-6B143C83554CQ59662753-2A59583C-B64A-4CB1-B0D3-F06727421822Q59662760-7DDC94AB-EADF-473D-BA3B-34BDB371FAB2Q79424401-66267673-78AC-48DE-9982-BDD8DE0C55CBQ81513239-DCC7C844-7AB3-406D-B614-4478EF2058BFQ83159650-4B2590A8-9BE5-4B04-8F20-E6E29E93AAF6Q85553441-C2D5167B-350B-4C3F-98D0-84BB480A1233Q86191935-A4EE8A96-FBD0-4255-B3D9-F8CD92740B6FQ91284105-743B4A55-B623-420A-9BA0-850410CF5A77
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Dániel Erdélyi
@en
Dániel Erdélyi
@nl
type
label
Dániel Erdélyi
@en
Dániel Erdélyi
@nl
prefLabel
Dániel Erdélyi
@en
Dániel Erdélyi
@nl
P31
P496
0000-0001-5544-9209